COX inhibitor Bromfenac sodium, Purity ≥98%

Cat. No.: X23-10-ZQ575

COX inhibitor Bromfenac sodium, Purity ≥98%

Synonym: BROMFENAC SODIUM; 91714-93-1; BromSite; Bronuck; 120638-55-3; Bromfenac (sodium); Bromfenac sodium salt; COX inhibitor

  • MDL: MFCD03701673
  • CAS Number: 91714-93-1
  • Compound CID: 23693301
Product Size
50 mg; 100 mg; 250 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Bromfenac sodium, soluble in DMSO, water and ethanol, blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions. It targets COX1 and COX2.
Molecular Weight
356.15
Molecular Formula
C15H12BrNO3.Na
Targets
COX1; COX2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 61 mg/mL (171.27 mM); Water: 61 mg/mL (171.27 mM); Ethanol: 2 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Bromfenac sodium can be used to study its role as an NSAID with anti-inflammatory and analgesic properties.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.